These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 7921283
1. [Immunohematologic surveillance of patients treated with ABO incompatible bone marrow allografts]. Mizon P, Jouet JP, Vanhaesbroucke C, Villard F, Wibaut B, Goudemand J. Transfus Clin Biol; 1994; 1(4):271-7. PubMed ID: 7921283 [Abstract] [Full Text] [Related]
2. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Rowley SD, Liang PS, Ulz L. Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656 [Abstract] [Full Text] [Related]
3. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Lee JH, Lee KH, Kim S, Lee JS, Kim SH, Kwon SW, Kim WK. Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677 [Abstract] [Full Text] [Related]
4. Isoagglutinins following ABO-incompatible bone marrow transplantation. Wernet D, Mayer G. Vox Sang; 1992 Jan; 62(3):176-9. PubMed ID: 1609520 [Abstract] [Full Text] [Related]
5. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation. Webb IJ, Soiffer RJ, Andersen JW, Cohen CA, Freeman A, Sugrue M, Ritz J, Anderson KC. Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922 [Abstract] [Full Text] [Related]
6. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT. Franchini M, de Gironcoli M, Gandini G, Vassanelli A, Rocca P, Benedetti F, Aprili G. Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284 [Abstract] [Full Text] [Related]
7. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE. Blood; 1992 Jun 01; 79(11):3076-85. PubMed ID: 1586749 [Abstract] [Full Text] [Related]
8. ABO-incompatible bone marrow transplantation. Wiesneth M, Hertenstein B, Bunjes D, Schmeiser T, Maccari B, Northoff H, Laasch H, Heit W, Arnold R, Heimpel H. Beitr Infusionsther; 1992 Jun 01; 30():354-8. PubMed ID: 1284733 [Abstract] [Full Text] [Related]
9. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation. Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J. Transfusion; 1983 Jun 01; 23(4):277-85. PubMed ID: 6410549 [Abstract] [Full Text] [Related]
10. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia. Ockelford PA, Hill RS, Nelson L, Blacklock HA, Woodfield DG, Matthews JR. Transfusion; 1982 Jun 01; 22(1):62-5. PubMed ID: 7039010 [Abstract] [Full Text] [Related]
11. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism. Mueller RJ, Stussi G, Odermatt B, Halter J, Schanz U, Seebach JD. Xenotransplantation; 2006 Mar 01; 13(2):126-32. PubMed ID: 16623806 [Abstract] [Full Text] [Related]
12. Erythrocyte depletion of ABO-incompatible bone marrow. Sniecinski I, Henry S, Ritchey B, Branch DR, Blume KG. J Clin Apher; 1985 Mar 01; 2(3):231-4. PubMed ID: 3897206 [Abstract] [Full Text] [Related]
13. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation. Bacigalupo A, Van Lint MT, Occhini D, Margiocco M, Ferrari G, Pittaluga PA, Frassoni F, Peralvo J, Lercari G, Carubia F. Transplantation; 1988 Jun 01; 45(6):1091-4. PubMed ID: 3289150 [Abstract] [Full Text] [Related]
14. Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. Lee JH, Lee JH, Choi SJ, Kim S, Seol M, Kwon SW, Park CJ, Chi HS, Lee JS, Kim WK, Lee KH. Br J Haematol; 2003 Feb 01; 120(4):702-10. PubMed ID: 12588361 [Abstract] [Full Text] [Related]
15. Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplant. López J, Steegmann JL, Pérez G, Otero MJ, Berberana M, Cámara R, Lamana M, Fernández Villalta MJ, Fernández-Rañada JM. Am J Hematol; 1994 Mar 01; 45(3):237-9. PubMed ID: 8296795 [Abstract] [Full Text] [Related]
16. Is the ABO incompatibility a risk factor in bone marrow transplantation? Rozman P, Kosir A, Bohinjec M. Transpl Immunol; 2005 Aug 01; 14(3-4):159-69. PubMed ID: 15982558 [Abstract] [Full Text] [Related]
17. A preliminary report on ABO incompatible bone marrow transplant. Tan P, Ong YW, Tien SL, Loh TF, Lim ST. Ann Acad Med Singap; 1991 Jul 01; 20(4):421-8. PubMed ID: 1799251 [Abstract] [Full Text] [Related]
18. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch. De Santis GC, Garcia-Silva AC, Dotoli GM, de Castro PT, Simões BP, Covas DT. Clin Transplant; 2017 Apr 01; 31(4):. PubMed ID: 28160319 [Abstract] [Full Text] [Related]
19. [Effect of ABO-incompatible allogeneic stem cell transplantation on erythroid lineage hematopoiesis]. Cai XJ, Hong JY, Chen Y, Yu K. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun 01; 19(3):801-4. PubMed ID: 21729575 [Abstract] [Full Text] [Related]
20. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility. Nussbaumer W, Schwaighofer H, Gratwohl A, Kilga S, Schönitzer D, Nachbaur D, Niederwieser D. Transfusion; 1995 Jul 01; 35(7):592-5. PubMed ID: 7631393 [Abstract] [Full Text] [Related] Page: [Next] [New Search]